| Profit growth | Value |
|---|---|
| 1Y (TTM) | +433% |
| 3Y CAGR | -51% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,383.90 -136.40 (5.41%) | 19,162.17 | 28.26 | 5.69 | ||
PfizerPFIZER | ₹3,863.00 -30.30 (0.78%) | 17,811.42 | 20.73 | 4.06 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,443.50 -63.50 (0.98%) | 16,277.75 | 91.59 | 18.52 | ||
Natco PharmaNATCOPHARM | ₹809.00 +0.05 (0.01%) | 15,862.14 | 13.86 | 1.51 |